Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 44Terminated 12Withdrawn 3Recruiting 2Active not recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neuroblastoma 1Neoplasm, Residual 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Biphenotypic, Acute 1Leukemia 1Intraocular Lymphoma 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1Burkitt Lymphoma 1

Interventions

Rituximab 3Cyclophosphamide 3zanubrutinib 2fludarabine 2tafasitamab 1resiniferatoxin 1obinutuzumab 1duvelisib 1Vincristine 1Vancomycin 1Thiotepa 1Surveys and Questionnaires 1Radiotherapy 1Prednisone 1Prednisolone 1PTH2 protein, human 1Observation 1Neuropsychological Tests 1Methotrexate 1Magnetic Resonance Spectroscopy 1Lisaftoclax 1Interleukin-2 1Injections, Subcutaneous 1Homoharringtonine 1Glucocorticoids 1Doxorubicin 1Dexamethasone 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Lymphoma, Non-Hodgkin × Methotrexate × Clear all
NCT06646211 2024-10-17

High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)

Sun Yat-sen University

Phase 2 Not yet recruiting
30 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡